XP Inc. · XP · FY2026 Q1 · Calendar Q2 2026

XP maintains growth focus amid credit-spread and efficiency risks

The supplied analysis supports a constructive but conditional view: XP is pursuing growth through retail platform expansion, fee-based models, private banking and technology, while credit conditions, efficiency and client sentiment remain important tests.

Reported After market closeNASDAQFinancial Services $10.92B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.47 Consensus $0.49
EPS surprise -3.6% Reported versus consensus
Reported revenue $909.7M Consensus $925.7M
Revenue surprise -1.7% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -3.9% Event window
SPY move -0.7% Same window
Abnormal move -3.2% Stock minus SPY
Volume 2.7× Versus trailing sessions
Subsequent drift -7.5% Up to 20 sessions
XPSPY benchmark

Ask FN2 about XP FY2026 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

The current-quarter analysis emphasized a stronger shift toward goal-based investing, managed portfolios and fee-based models, alongside continued capital distributions and a new managerial P&L structure. The prior analysis had highlighted broader product expansion and technology-led adviser augmentation.

Guidance delta

Maintained

Key takeaways

  • Management presented a confident growth outlook despite macro volatility.
  • Retail net new money, goal-based investing and private banking are central growth areas.
  • The company is expanding fee-based models while continuing technology and adviser-productivity investment.
  • Capital distribution and a new reporting structure were important developments in the supplied analysis.

Management priorities

  • Scale goal-based investing and managed portfolios
  • Increase flat-fee and fee-based models
  • Expand private banking and cross-selling
  • Invest in technology and adviser productivity
  • Continue shareholder distributions

Follow XP with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
XP EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 estimate $0.41 Q4 '23 actual $0.43, beat Q1 '24 estimate $0.39 Q1 '24 actual $0.36, miss Q2 '24 estimate $0.35 Q2 '24 actual $0.39, beat Q2 '25 estimate $0.43 Q2 '25 actual $0.43, match Q3 '25 estimate $0.46 Q3 '25 actual $0.45, match Q4 '25 estimate $0.45 Q4 '25 actual $0.46, match Q1 '26 estimate $0.49 Q1 '26 actual $0.47, miss Q2 '26 estimate $0.50 Q2 '26 actual $0.53, beat Q3 '26 estimate $2.74 Q4 '26 estimate $2.88 Q1 '27 estimate $2.97 Q2 '27 estimate $3.00
Show 1 more >

Analyst Consensus ?

ConsensusBuy10 ratings
Bullish880.0%
Neutral220.0%
Bearish00.0%

Analyst 52W Price Targets

$20.88Previous close
$19Low
$25.5Average
$33High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Itau BBA Outperform Market PerformUpgradeAug 31, 2026
UBS Buy BuyMaintainJun 3, 2026
Citigroup Buy BuyMaintainSep 24, 2025
Goldman Sachs Buy NeutralUpgradeJun 4, 2025
B of A Securities Neutral NeutralMaintainMay 21, 2025
Show 5 more rating actions

Named analyst price targets

Upside is calculated against the persisted previous close $20.88. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
JefferiesAnalyst unavailable$22$17.4 +5.4%Jan 19, 2026
UBSThiago Batista$25$17.58 +19.7%Dec 16, 2025
UBSThiago Batista$23$16.53 +10.2%Oct 16, 2025
UBSThiago Batista$21$18.25 +0.6%Jul 11, 2024
BradescoGustavo Schroden$19$16.7 -9.0%Jul 2, 2024
See 5 more

Track every rating change on XP the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

XP Inc. provides financial products and services in Brazil. The company operates XP Platform, an open product platform that provides clients to access investment products in the market comprising brokerage securities, fixed income securities, mutual, hedge, and private equity funds; derivatives and synthetic instruments; credit cards; loan operations/collateralized credit products; pension and social security funds, and life and travel insurance products; and other investment products comprising real estate funds, and equity and debt capital markets solutions, as well as wealth management services. It offers brokerage and issuer services to institutional and corporate clients.…

Historical context

All XP earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the XP recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-19T14:21:13.684712+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-24T11:40:54.666601+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T11:40:54.663834+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.